Prolonged ventricular asystole: A rare adverse effect of hydrocodone use

American Journal of Case Reports

Volumn 15, Issue , 2014, Pages 450-453

  Sudhakaran, Sivakumar ^a   Surani, Saherish S ^b   Surani, Salim R ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b Pulmonary Associates of Corpus Christi   (United States)

Author keywords

Arrhythmias; Cardiac; Heart arrest

Indexed keywords

HYDROCODONE; HYDROCODONE PLUS PARACETAMOL; ISOPRENALINE; PARACETAMOL; UNCLASSIFIED DRUG; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; ATRIOVENTRICULAR BLOCK; CASE REPORT; CONSCIOUSNESS DISORDER; DIAPHORESIS; DIZZINESS; DRUG WITHDRAWAL; EMERGENCY WARD; FAINTNESS; FEMALE; FOOT PAIN; HEADACHE; HEART ARREST; HEART ARRHYTHMIA; HEART RATE; HUMAN; NAUSEA; PRESYNCOPE; RETCHING; SINUS BRADYCARDIA; SINUS RHYTHM; SYMPTOM; WEAKNESS; CHEMICALLY INDUCED; DRUG EFFECTS; ELECTROCARDIOGRAPHY; HEART VENTRICLE; MIDDLE AGED; PATHOPHYSIOLOGY; SYNCOPE, VASOVAGAL;

ANALGESICS, OPIOID; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HEART VENTRICLES; HUMANS; HYDROCODONE; MIDDLE AGED; SYNCOPE, VASOVAGAL;

EID: 84908237064     PISSN: None     EISSN: 19415923     Source Type: Journal    
DOI: 10.12659/AJCR.891214     Document Type: Article

References (15)

1. van Lieshout JJ, Wieling W, Karemaker JM, Eckberg DL: The vasovagal response. Clin Sci (Lond), 1991; 81(5): 575-86
2. Alboni P, Holz A, Brignole M: Vagally mediated atrioventricular block: pathophysiology and diagnosis. Heart, 2013; 99(13): 904-8
3. Ganzeboom KS, Mairuhu G, Reitsma JB et al: Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol, 2006; 17(11): 1172-76
4. Sun BC, Emond JA, Camargo CA Jr: Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol, 2005; 95(5): 668-71
5. White CM, Tsikouris JP: A review of pathophysiology and therapy of patients with vasovagal syncope. Pharmacotherapy, 2000; 20(2): 158-65
6. Klein KM, Berkovic SF: Genetics of vasovagal syncope. Auton Neurosci, 2014; pii: S1566-0702(14)00056-3
7. Chou HH, Lin KH, Luqman N, Kuo CT et al: Prolonged ventricular asystole, sinus arrest, and paroxysmal atrial flutter-fibrillation: an uncommon presentation of vasovagal syncope. Pacing Clin Electrophysiol, 2003; 26(4 Pt 1): 914-17
8. Arias MA, Puchol A, Castellanos E et al: Extremely prolonged ventricular asystole. Indian Pacing Electrophysiol J, 2009; 9(5): 283
9. Moya A, Sutton R, Ammirati F et al: Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J, 2009; 30(21): 2631-71
10. Raviele A, Gasparini G, Di Pede F et al: Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J, 1994; 127(1): 103-11
11. Sheldon R, Koshman ML: A randomized study of tilt test angle in patients with undiagnosed syncope. Can J Cardiol, 2001; 17(10): 1051-57
12. Lazarus JC, Mauro VF: Syncope: pathophysiology, diagnosis, and pharmacotherapy. Ann Pharmacother, 1996; 30(9): 994-1005
13. Aydin MA, Salukhe TV, Wilke I, Willems S et al: Management and therapy of vasovagal syncope: A review. World J Cardiol, 2010; 2(10): 308-15
14. Vardas PE, Auricchio A, Blanc JJ et al: Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace, 2007; 9(10): 959-98
15. Vaddadi G, Corcoran SJ, Esler M: Management strategies for recurrent vasovagal syncope. Intern Med J, 2010; 40(8): 554-60